In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus

International Journal of Hygiene and Environmental Health

Volumn 217, Issue 1, 2014, Pages 17-22

  Cegolon, L ^a,b   Salata, C ^a   Piccoli, E ^a   Juarez, V ^c   Palu', G ^a   Mastrangelo, G ^a   Calistri, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ALAXIA SAS   (France)

Author keywords

A H1N1 2009; Disinfection; Hypothiocyanite; In vitro; Infection control; Influenza prophylaxis; Influenza treatment; Neuroaminidase; OSCN lactoperoxidase

Indexed keywords

BACTERIA (MICROORGANISMS); FUNGI; ORTHOMYXOVIRIDAE;

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ANTIVIRUS AGENT; CARBON DIOXIDE; DNA; DUAL OXIDASE; FETAL BOVINE SERUM; HEMAGGLUTININ; HYPOTHIOCYANITE; HYPOTHIOCYANITE ION; LACTOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PHOSPHATE BUFFERED SALINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RNA; SIALIDASE; SODIUM; THIOCYANATE; THIOCYANIC ACID DERIVATIVE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYL TETRAZOLIUM BROMIDE; 5-THIO-2-NITROBENZOIC ACID; 5′5 DITHIO-BIS-2-NITROBENZOATE; A/H1N1/2009; AMERICAN TISSUE CULTURE COLLECTION; ANIMAL; ARTICLE; ATCC; CELL LINE; CO(2); DISINFECTION; DOG; DRUG EFFECT; DUOX; FBS; HA; HOSCN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOTHIOCYANITE ANION; HYPOTHIOCYANOUS ACID; IN VITRO STUDY; INFECTION CONTROL; INFLUENZA PROPHYLAXIS; INFLUENZA TREATMENT; INFLUENZA VIRUS A H1N1; L-1-TOSYLAMIDE-2-PHENYLETHYL CHLOROMETHYL KETONE; LPO; MADIN-DARBY CANINE KIDNEY; MDCK; MEM; MINIMAL ESSENTIAL MEDIUM; MTT; OD; OPTICAL DENSITY; OSCN(-); OSCN(-) LACTOPEROXIDASE; PANDEMIC; PBS; PHYSIOLOGY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTASE REAL-TIME POLYMERASE CHAIN REACTION; RRT-PCR; RSV; SCN(-); SDS; SEQUENCE DETECTION SYSTEMS SOFTWARE; TCID; TISSUE CULTURE INFECTIOUS DOSE; TNB; VIRUS ENTRY;

3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYL TETRAZOLIUM BROMIDE; 5-THIO-2-NITROBENZOIC ACID; 5′5 DITHIO-BIS-2-NITROBENZOATE; A/H1N1/2009; AMERICAN TISSUE CULTURE COLLECTION; ATCC; CARBON DIOXIDE; CO(2); DEOXYRIBONUCLEIC ACID; DISINFECTION; DNA; DTNB; DUAL OXIDASE; DUOX; FBS; FETAL BOVINE SERUM; HA; HEMAGGLUTININ; HIV; HOSCN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOTHIOCYANITE; HYPOTHIOCYANITE ANION; HYPOTHIOCYANOUS ACID; IN VITRO; INFECTION CONTROL; INFLUENZA PROPHYLAXIS; INFLUENZA TREATMENT; L-1-TOSYLAMIDE-2-PHENYLETHYL CHLOROMETHYL KETONE; LACTOPEROXIDASE; LPO; MADIN-DARBY CANINE KIDNEY; MDCK; MEM; MINIMAL ESSENTIAL MEDIUM; MTT; NA; NADPH; NEURAMINIDASE; NEUROAMINIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OD; OPTICAL DENSITY; OSCN(-); OSCN(-) LACTOPEROXIDASE; PBS; PHOSPHATE BUFFERED SALINE; RESPIRATORY SYNCYTIAL VIRUS; REVERSE TRANSCRIPTASE REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEIC ACID; RNA; RRT-PCR; RSV; SCN(-); SDS; SEQUENCE DETECTION SYSTEMS SOFTWARE; TCID; THIOCYANATE; TISSUE CULTURE INFECTIOUS DOSE; TNB; TPCK;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; INFLUENZA A VIRUS, H1N1 SUBTYPE; PANDEMICS; THIOCYANATES; VIRUS INTERNALIZATION;

EID: 84887618463     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2013.03.001     Document Type: Article

References (44)

1. Aitken C., Jefferies D.J. Nosocomial spread of viral disease. Clin. Microbiol. Rev. 2001, 14:528-546.
2. Barker J., Stevens D., Bloomfield S.F. Spread and prevention of some common viral infections in community facilities and domestic homes. J. Appl. Microbiol. 2001, 91:7-21.
3. Barrett T.J., Hawkins C.L. Hypothiocyanous acid benign or deadly?. Chem. Res. Toxicol. 2011, 25:263-273.
4. Björck L., Rosén C.G., Marshall V., Reiter B. Antibacterial activity of the lactoperoxidase system in milk against pseudomonads and other gram-negative bacteria. Appl. Microbiol. 1975, 30:199-204.
5. Boone S.A., Gerba C.P. The occurrence of influenza A virus on household and day care center fomites. J. Infect. 2005, 51:103-109.
6. Brankston G., Gitterman L., Hirji Z., Lemieux C., Gardam M. Transmission of influenza A in human beings. Lancet Infect. Dis. 2007, 7:257-265.
7. Carlsson J., Edlund M.B.K., Hanstrom L. Bactericidal and cytotoxic effects of hypothiocyanite-hydrogen peroxide mixtures. Infect. Immun. 1984, 44:581-586.
8. Conner G.E., Wijkstrom-Frei C., Randell S.H., Fernandez V.E., Salathe M. The lactoperoxidase system links anion transport to host defense in cystic fibrosis. FEBS Lett. 2007, 581:271-278.
9. Couch R.B. Prevention and treatment of influenza. N. Engl. J. Med. 2000, 343(24):1778-1787. December 14.
10. Couch R.B. Medical Microbiology 1995, 1-22. University of Texas Medical Branch, Galveston.
11. Cummings K.J., Cox-Ganser J., Riggs M.A., Edwards N., Kreiss K. Respirator donning in post-hurricane new orleans. Emerg. Infect. Dis. 2007 May, 13(5):700-707.
12. Gerson C., Sabater J., Scuri M., et al. The lactoperoxidase system functions in bacterial clearance of airways. Am. J. Respir. Cell Mol. Biol. 2000, 22:665-671.
13. Grasberger H., Refetoff S. Identification of the maturation factor for dual oxidase: evolution of an eukaryotic operon equivalent. J. Biol. Chem. 2006, 281:18269-18272.
14. Herfst S. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012, 336:1534-1541.
15. Heymann D.L. Control of Communicable Diseases Manual 2008, American Public Health Association, Washington, DC.
16. Ihalin R., Loimaranta V., Lenander-Lumikari M., Tenovuo J. The effects of different (pseudo) halide substrates on peroxidase-mediated killing of Actinobacillus actinomycetemcomitans. J. Periodontal Res. 1998, 33:421-427.
17. Jalil R.A. Concentrations of thiocyanate and hypothiocyanite in the saliva of young adults. J. Nihon Univ. Sch. Dent. 1994, 36(December (4)):254-260.
18. Jefferson T., Demicheli V., Rivetti D., Jones M., Di Pietrantonj C., Rivetti A. Antivirals for influenza in healthy adults: systematic review. The Lancet 2006, 367:303-313.
19. Kirstilä V., Lenander-Lumikari M., Söderling E., Tenovuo J. Effects of oral hygiene products containing lactoperoxidase, lysozyme, and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients with xerostomia. Acta Odontol. Scand. 1996 Dec, 54(6):391-397.
20. Klimov A., Balish A., Veguilla V., Sun H., Schiffer J., Lu X., Katz J.M., Hancock K. Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol. Biol. 2012, 865:25-51.
21. Lemieux C., Brankston G., Gitterman L., Hirji Z., Gardam M. Questioning aerosol transmission of influenza. Emerg. Infect. Dis. 2007, 13:173-175.
22. 2 system. Oral Microbiol. Immunol. 1992, 7:315-320.
23. Marcozzi G., Liberati V., Madia F., Pizzinga A., de Feo G. Effect of hormone replacement therapy on lacrimal fluid peroxidase activity in woman. Maturitas 2003, 45(3):225-229.
24. Mastrangelo G., Zanibellato R., Fadda E., Lange J.H., Scoizzato L., Rylander R. Exposure to hydrogen peroxide and eye and nose symptoms among workers in a beverage processing plant. Ann. Occup. Hyg. 2009, 53(March (2)):161-165.
25. Mastrangelo G., Zanibellato R., Fedeli U., Fadda E., Lange J.H. Exposure to hydrogen peroxide at TLV level does not induce lung function changes: a longitudinal study. Int. J. Environ. Health Res. 2005, 15(August (4)):313-317.
26. Mikola H., Waris M., Tenovuo J. Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite. Antiviral Res. 1995, 26:161-171.
27. Moskwa P., Lorentzen D., Excoffon K.J., Zabner J., McCray P.B., Nauseef W.M., Dupuy C., Banfi B. A novel host defense system of airways is defective in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2007, 175:174-183.
28. Nagy P., Jameson G.N.L., Winterbourn C.C. Kinetics and mechanisms of the reaction of hypothiocyanous acid with 5-thio-2-nitrobenzoic acid and reduced glutathione. Chem. Res. Toxicol. 2009, 22:1833-1840.
29. Palese P. Orthomixoviridae 2007, Lippincott Williams & Wilkins, Philadelphia, PA. fifth ed.
30. Pourtois M., Binet C., Van Tieghem N., Courtois P., Vandenabbeele A., Thiry L. Inhibition of HIV infectivity by lactoperoxidase-produced hypothiocyanite. J. Biol. Buccale 1990, 18:251-253.
31. Pruitt K., Reiter B. Biochemistry of peroxidase system: antimicrobial effects. The Lactoperoxidase System 1985, 143-178. Marcel Dekker, Inc., New York. K.M. Pruitt, J.O. Tenovuo (Eds.).
32. Reiter B., Marshall V.M.E., Bjorck L., Rosen C-G. Nonspecific bactericidal activity of the lactoperoxidase-thiocyanatehydrogen peroxide system of milk against Escherichia coli and some gram-negative pathogens. Infect. Immun. 1976, 13:800-807.
33. Reiter B., Perraudin J-P. Lactoperoxidase: biological functions. Peroxidases in Chemistry and Biology 1991, Vol. I:144-180. CRC Press, Boca Raton, FL.
34. Schaffer F.L., Soergel M.E., Straure D.C. Survival of airborne influenza virus: effects of propagating host, relative humidity, and composition of spray fluids. Archives of Virology 1976, 51:263-273.
35. Shin K., Wakabayashi H., Yamuchi K., Teraguchi S., Tamura Y., Kurokawa M., Shiraki M. Effect of orally administered bovine lactoferrine and Lactoperoxidase on influenza virus infection in mice. J. Med. Microbiol. 2005, 54:7174-7723.
36. Tellier R. Review of aerosol transmission of influenza A virus. Emerg. Infect. Dis. 2006, 12:1657-1662.
37. Tellier R. Transmission of influenza A in human beings. Lancet Infect. Dis. 2007, 7:759-760.
38. Tenovuo J., Lehtonen O.P., Aaltonen A.S., Vilja P., Tuohimaa P. Antimicrobial factors in whole saliva of human infants. Infect. Immun. 1986, 51(January (1)):49-53.
39. Tenovuo J., Pruitt K.M., Thomas E.L. Peroxidase antimicrobial system of human saliva: hypothiocyanite levels in resting and stimulated saliva. J. Dent. Res. 1982, 61:982-985.
40. Thomas E.L., Aune T.M. Lactoperoxidase, peroxide, thiocyanate antimicrobial system: correlation of sulfhydryl oxidation with antimicrobial action. Infect. Immun. 1978, 20:456-463.
41. Thomas E.L., Bates K.P., Jefferson M.M. Hypothiocyanite ion: detection of the anti-microbial agent in human saliva. J. Dent. Res. 1980, 59:1466-1472.
42. Weber A., Willeke K., Marchioni R., et al. Aerosol penetration and leakage characteristics of masks used in the health care industry. Am. J. Infect. Control. 1993, 21:167-173.
43. Weber T.P., Stilianakis N.I. Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J. Infect. 2008, 57:361-373.
44. Zachary, K.C., Hirsch, M.S., Thorner, A.R., 2012. Prevention of seasonal influenza in adults. Available at: (accessed May 2012). http://www.uptodate.com/contents/prevention-of-seasonal-influenza-in%20adults%3Fsource=search_result%26search=prevention+influenza%26selectedTitle=1~150.